Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real
Three-quarters of primary care survey respondents prescribe GLP-1 RAs for weight loss and half get questions daily about the drugs. See all the results.
Half of family practice and internal medicine specialists field patient questions on a daily basis about glucagon-like peptide 1 receptor agonists (GLP-1RAs) for weight loss while more than one-third are queried weekly, according to results from an early October survey by primary care partner websites Patient Care and Medical Economics.
The survey also revealed concern among frontline health care professionals about the popularity and shortages of the antiobesity medications, reflected by responses from more than three-quarters that they worry their patients will seek out GLP-1 RAs from online sources without consulting them first.
Click through the rest of the findings on what primary care clinicians think about this class of drugs, how they select patients for GLP-1RA therapy, and what they feel are the most important unanswered questions about the "miracle" drugs.
